Table 1 Distribution of genotypes of vitamin D receptors, estrogen receptors, and obesity receptors in studied non-osteoporotic and osteoporotic women
Parameters | Non-osteoporotic N = 45 %46.39 | Osteoporotic N = 52 %53.61 | Chi-square P |
|---|---|---|---|
Taq1 vit. D receptor gene | |||
Homozygous | 26 (57.78%) | 34 (65.38%) | 0.442 |
Heterozygous | 19 (42.22%) | 18 (34.62%) | |
Mutant | 0.0 (0.0%) | 0.0(0.0%) | |
Apa1 vit. D receptor gene | |||
Homozygous | 36(80.0%) | 33 (63.46%) | 0.162 |
Heterozygous | 9 (20.0%) | 18 (34.62%) | |
Mutant | 0 (0.00%) | 1(1.92%) | |
Xba1 estrogen receptor gene | |||
Homozygous | 45 (100%) | 52 (100%0) | ------- |
Heterozygous | 0.0 | 0.0 | |
Mutant | 0.0 | 0.0 | |
Pvu11 estrogen receptor gene | |||
Homozygous | 32 (71.11%) | 35 (67.31%) | 0.686 |
Heterozygous | 13(28.89%) | 17 (32.69%) | |
Mutant | 0.0 | 0.0 | |
FTOrs99 obesity receptor gene | |||
Homozygous | 27 (60.00%) | 30 (57.69%) | 0.615 |
Heterozygous | 16 (35.56%) | 17 (32.69%) | |
Mutant | 2 (4.44%) | 5 (11.11%) | |
FTOrs80 obesity receptor gene | |||
Homozygous | 27 (60.00%) | 24 (46.15%) | 0.268 |
Heterozygous | 16 (35.56%) | 22 (42.31%) | |
Mutant | 2 (4.44%) | 6 (11.54%) | |